Your browser doesn't support javascript.
loading
Childhood nephroblastoma in Southern and Eastern Europe and the US: Incidence variations and temporal trends by human development index.
Doganis, Dimitrios; Panagopoulou, Paraskevi; Tragiannidis, Athanasios; Georgakis, Marios K; Moschovi, Maria; Polychronopoulou, Sofia; Rigatou, Efthimia; Papakonstantinou, Eugenia; Stiakaki, Eftichia; Dana, Helen; Bouka, Evdoxia; Antunes, Luis; Bastos, Joana; Coza, Daniela; Demetriou, Anna; Agius, Domenic; Eser, Sultan; Ryzhov, Anton; Sekerija, Mario; Trojanowski, Maciej; Zagar, Tina; Zborovskaya, Anna; Perisic, Snezana Zivkovic; Stefanaki, Kalliopi; Dessypris, Nick; Petridou, Eleni Th.
Affiliation
  • Doganis D; Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Greece; Oncology Department, P & A Kyriakou Children's Hospital, Athens, Greece.
  • Panagopoulou P; Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Greece.
  • Tragiannidis A; Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Greece; Hematology-Oncology Unit, 2nd Pediatric Department, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece.
  • Georgakis MK; Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Greece.
  • Moschovi M; Pediatric Hematology-Oncology Unit, First Department of Pediatrics, University of Athens, 'Agia Sofia' Children's Hospital, Athens, Greece.
  • Polychronopoulou S; Department of Pediatric Hematology-Oncology, 'Agia Sofia' Children's Hospital, Athens, Greece.
  • Rigatou E; Department of Pediatric Hematology-Oncology, 'Agia Sofia' Children's Hospital, Athens, Greece.
  • Papakonstantinou E; Department of Pediatric Hematology and Oncology, Hippokration Hospital, Thessaloniki, Greece.
  • Stiakaki E; Department of Pediatric Hematology-Oncology, University of Crete, Heraklion, Greece.
  • Dana H; Pediatric Hematology-Oncology Department, "Mitera" Children's Hospital, Athens, Greece.
  • Bouka E; Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Greece.
  • Antunes L; North Region Cancer Registry of Portugal (RORENO), Portuguese Institute of Oncology, Porto, Portugal.
  • Bastos J; Registo Oncológico Regional do Centro (ROR-Centro), Instituto Português de Oncologia de Coimbra Francisco Gentil, E.P.E., Coimbra, Portugal.
  • Coza D; Cluj Regional Cancer Registry, The Oncology Institute 'Prof. Dr. Ion Chiricuta', Cluj-Napoca, Romania.
  • Demetriou A; Health Monitoring Unit, Ministry of Health, Nicosia, Cyprus.
  • Agius D; Malta National Cancer Registry, Department for Policy in Health-Health Information and Research, Pieta, Malta.
  • Eser S; Izmir Cancer Registry, Izmir Hub, Izmir and Hacettepe, University Institute of Public Health, Ankara, Turkey.
  • Ryzhov A; National Cancer Registry of Ukraine, National Institute of Cancer, Kiev, Ukraine.
  • Sekerija M; Croatian Institute of Public Health, Croatian National Cancer Registry, Zagreb, Croatia; Andrija Stampar School of Public Health, School of Medicine, University of Zagreb, Croatia.
  • Trojanowski M; Greater Poland Cancer Registry, Greater Poland Cancer Center, Poznan, Poland.
  • Zagar T; Cancer Registry of Slovenia, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Zborovskaya A; Belarusian Research Center for Paediatric Oncology, Haematology and Immunology, Childhood Cancer Subregistry of Belarus, Minsk, Belarus.
  • Perisic SZ; Institute of Public Health of Serbia, Central Serbia Cancer Registry, Dr. Subotica 5, 11000, Belgrade, Serbia.
  • Stefanaki K; Department of Pathology, 'Aghia Sophia' Children's Hospital, Athens, Greece.
  • Dessypris N; Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Greece.
  • Petridou ET; Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Greece; Clinical Epidemiology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden. Electronic address: epetrid@med.uoa.gr.
Cancer Epidemiol ; 54: 75-81, 2018 06.
Article in En | MEDLINE | ID: mdl-29655086
ABSTRACT

BACKGROUND:

Despite advances in the management of nephroblastoma (Wilms' tumor, WT), the etiology of the tumor remains obscure. We aimed to compare nephroblastoma incidence rates and time trends among children (0-14 years) in 12 Southern and Eastern European (SEE) countries and the Surveillance, Epidemiology, and End Results Program (SEER), USA, in relation to the human development index (HDI).

METHODS:

In total 1776 WT cases were recorded in 13 SEE collaborating registries (circa 1990-2016), whereas data on 2260 cases (1990-2012) were extracted from the SEER database. Age-standardized incidence rates (AIRs) were calculated and correlated with HDI, whereas temporal trends were evaluated using Poisson regression and Joinpoint analyses.

RESULTS:

The overall SEE AIR (9.2/106) was marginally higher than that of the SEER (8.3/106), whereas significant differences were noted among the 13 SEE registries which comprised mainly Caucasian populations. A statistically significant temporal increase in incidence was noted only in Belarus. Most cases (∼75%) were diagnosed before the fifth year of life, with rates steadily declining thereafter; median age at diagnosis was similar in SEE countries and SEER. A slight male preponderance in the first year of life (malefemale = 1.1) was followed by a female preponderance in the older age groups (malefemale = 0.7). Lastly, a statistically significant positive association between higher HDI and increasing nephroblastoma incidence was noted (regression coefficient +3.25, 95%CI +1.35, +5.15).

CONCLUSIONS:

Variations in incidence and time trends across the examined registries, changing male-to-female patterns with advancement in age, and positive associations with the HDI imply a plausible role for environmental and genetic factors in disease etiology, and these need to be explored further.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Registries / Wilms Tumor Type of study: Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: America do norte / Europa Language: En Journal: Cancer Epidemiol Journal subject: EPIDEMIOLOGIA / NEOPLASIAS Year: 2018 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Registries / Wilms Tumor Type of study: Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: America do norte / Europa Language: En Journal: Cancer Epidemiol Journal subject: EPIDEMIOLOGIA / NEOPLASIAS Year: 2018 Document type: Article Affiliation country: